106 related articles for article (PubMed ID: 37205792)
1. Activation of CTHRC1 by HOXB9 Promotes Angiogenesis through Fatty Acid Metabolism in Lung Adenocarcinoma.
Liu K; Li X; Yang Z; Zhang R
Rev Invest Clin; 2022; 75(2):63-75. PubMed ID: 37205792
[TBL] [Abstract][Full Text] [Related]
2. CTHRC1 targeted by miR-30a-5p regulates cell adhesion, invasion and migration in lung adenocarcinoma.
Yang C; Huang T; Liang Y; Xue Y; Liang Y; Wei X; Meng F; Wei Q
J Cardiothorac Surg; 2022 Mar; 17(1):46. PubMed ID: 35313900
[TBL] [Abstract][Full Text] [Related]
3. The AMPK-HOXB9-KRAS axis regulates lung adenocarcinoma growth in response to cellular energy alterations.
Wang T; Guo H; Li Q; Wu W; Yu M; Zhang L; Li C; Song J; Wang Z; Zhang J; Tang Y; Kang L; Zhang H; Zhan J
Cell Rep; 2022 Aug; 40(8):111210. PubMed ID: 36001969
[TBL] [Abstract][Full Text] [Related]
4. The impact of SOX4-activated CTHRC1 transcriptional activity regulating DNA damage repair on cisplatin resistance in lung adenocarcinoma.
Ai C; Huang Z; Rong T; Shen W; Yang F; Li Q; Bi L; Li W
Electrophoresis; 2024 Apr; ():. PubMed ID: 38629299
[TBL] [Abstract][Full Text] [Related]
5. Transcription Factor MITF Inhibits the Transcription of CPT1B to Regulate Fatty Acid β-Oxidation and Thus Affects Stemness in Lung Adenocarcinoma Cells.
Tang W; Tang H; Xu S; Yu H; Chen Z
Pharmacology; 2024; 109(1):52-64. PubMed ID: 38016436
[TBL] [Abstract][Full Text] [Related]
6. High expression of transcriptional factor HoxB9 predicts poor prognosis in patients with lung adenocarcinoma.
Zhan J; Wang P; Niu M; Wang Y; Zhu X; Guo Y; Zhang H
Histopathology; 2015 Jun; 66(7):955-65. PubMed ID: 25324169
[TBL] [Abstract][Full Text] [Related]
7. Elevated HOXB9 expression promotes differentiation and predicts a favourable outcome in colon adenocarcinoma patients.
Zhan J; Niu M; Wang P; Zhu X; Li S; Song J; He H; Wang Y; Xue L; Fang W; Zhang H
Br J Cancer; 2014 Aug; 111(5):883-93. PubMed ID: 25025961
[TBL] [Abstract][Full Text] [Related]
8. GalNAc-T14 promotes metastasis through Wnt dependent HOXB9 expression in lung adenocarcinoma.
Kwon OS; Oh E; Park JR; Lee JS; Bae GY; Koo JH; Kim H; Choi YL; Choi YS; Kim J; Cha HJ
Oncotarget; 2015 Dec; 6(39):41916-28. PubMed ID: 26544896
[TBL] [Abstract][Full Text] [Related]
9. Bevacizumab terminates homeobox B9-induced tumor proliferation by silencing microenvironmental communication.
Hoshino Y; Hayashida T; Hirata A; Takahashi H; Chiba N; Ohmura M; Wakui M; Jinno H; Hasegawa H; Maheswaran S; Suematsu M; Kitagawa Y
Mol Cancer; 2014 May; 13():102. PubMed ID: 24885802
[TBL] [Abstract][Full Text] [Related]
10. PAR2 promotes tumor-associated angiogenesis in lung adenocarcinoma through activating EGFR pathway.
Li Y; Huang H; Chen X; Yu N; Ye X; Chen L; Huang Z
Tissue Cell; 2022 Dec; 79():101918. PubMed ID: 36148733
[TBL] [Abstract][Full Text] [Related]
11. An E2F1-HOXB9 transcriptional circuit is associated with breast cancer progression.
Zhussupova A; Hayashida T; Takahashi M; Miyao K; Okazaki H; Jinno H; Kitagawa Y
PLoS One; 2014; 9(8):e105285. PubMed ID: 25136922
[TBL] [Abstract][Full Text] [Related]
12. High expression of HOXB3 predicts poor prognosis and correlates with tumor immunity in lung adenocarcinoma.
Yan M; Yin X; Zhang L; Cui Y; Ma X
Mol Biol Rep; 2022 Apr; 49(4):2607-2618. PubMed ID: 35028857
[TBL] [Abstract][Full Text] [Related]
13. PCAF-mediated acetylation of transcriptional factor HOXB9 suppresses lung adenocarcinoma progression by targeting oncogenic protein JMJD6.
Wan J; Xu W; Zhan J; Ma J; Li X; Xie Y; Wang J; Zhu WG; Luo J; Zhang H
Nucleic Acids Res; 2016 Dec; 44(22):10662-10675. PubMed ID: 27613418
[TBL] [Abstract][Full Text] [Related]
14. High CTHRC1 expression may be closely associated with angiogenesis and indicates poor prognosis in lung adenocarcinoma patients.
Chen Y; Sun Y; Cui Y; Lei Y; Jiang N; Jiang W; Wang H; Chen L; Luo J; Chen Y; Tang K; Zhou C; Ke Z
Cancer Cell Int; 2019; 19():318. PubMed ID: 31798347
[TBL] [Abstract][Full Text] [Related]
15. Homeodomain-containing protein HOXB9 regulates expression of growth and angiogenic factors, facilitates tumor growth in vitro and is overexpressed in breast cancer tissue.
Shrestha B; Ansari KI; Bhan A; Kasiri S; Hussain I; Mandal SS
FEBS J; 2012 Oct; 279(19):3715-3726. PubMed ID: 22863320
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-147b promotes lung adenocarcinoma cell aggressiveness through negatively regulating microfibril-associated glycoprotein 4 (MFAP4) and affects prognosis of lung adenocarcinoma patients.
Feng YY; Liu CH; Xue Y; Chen YY; Wang YL; Wu XZ
Gene; 2020 Mar; 730():144316. PubMed ID: 31884109
[TBL] [Abstract][Full Text] [Related]
17. CCAT1/FABP5 promotes tumour progression through mediating fatty acid metabolism and stabilizing PI3K/AKT/mTOR signalling in lung adenocarcinoma.
Chen J; Alduais Y; Zhang K; Zhu X; Chen B
J Cell Mol Med; 2021 Oct; 25(19):9199-9213. PubMed ID: 34431227
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-140-3p represses the proliferation, migration, invasion and angiogenesis of lung adenocarcinoma cells via targeting TYMS (thymidylate synthetase).
Wan S; Liu Z; Chen Y; Mai Z; Jiang M; Di Q; Sun B
Bioengineered; 2021 Dec; 12(2):11959-11977. PubMed ID: 34818974
[TBL] [Abstract][Full Text] [Related]
19. Silencing of HOXB9 suppresses cellular proliferation, angiogenesis, migration and invasion of prostate cancer cells.
Xu H; Wu S; Shen X; Wu D; Qin Z; Wang H; Chen X; Sun X
J Biosci; 2020; 45():. PubMed ID: 32098919
[TBL] [Abstract][Full Text] [Related]
20. USF1-induced overexpression of long noncoding RNA WDFY3-AS2 promotes lung adenocarcinoma progression via targeting miR-491-5p/ZNF703 axis.
Ren P; Hong X; Chang L; Xing L; Zhang H
Mol Carcinog; 2020 Aug; 59(8):875-885. PubMed ID: 32275336
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
